High expression of an intragenic long noncoding RNA misinterpreted as high FTO oncogene expression in NPM1 mutant acute myeloid leukemia-Reference-Cited by-同舟云学术

High expression of an intragenic long noncoding RNA misinterpreted as high FTO oncogene expression in NPM1 mutant acute myeloid leukemia

Published:2023-02-18 Issue:4 Volume:37 Page:901-904
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Arza-Apalategi Saioa^ORCID,Heuts Branco M. H.,Dooijes Meike T. M.,Gilissen Daan^ORCID,van der Heijden Adrian J. P.^ORCID,Jansen Joop H.,Martens Joost H. A.^ORCID,van der Reijden Bert A.^ORCID

Funder

Stichting Kinderen Kankervrij

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-023-01844-w.pdf

Reference15 articles.

1. Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, et al. FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase. Cancer Cell. 2017;31:127–41.

2. Lan N, Lu Y, Zhang Y, Pu S, Xi H, Nie X, et al. FTO—a common genetic basis for obesity and cancer. Front Genet. 2020;11:559138.

3. Huang Y, Su R, Sheng Y, Dong L, Dong Z, Xu H, et al. Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia. Cancer Cell. 2019;35:677–91.e10.

4. Qing Y, Su R, Chen J. Targeting FTO for cancer therapy and more. Aging. 2021;13:19080–2.

5. Xiao Q, Lei L, Ren J, Peng M, Jing Y, Jiang X, et al. Mutant NPM1-regulated FTO-mediated m(6)A demethylation promotes leukemic cell survival via PDGFRB/ERK signaling axis. Front Oncol. 2022;12:817584.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia;Experimental Hematology & Oncology;2024-01-24

2. Differentiation block in acute myeloid leukemia regulated by intronic sequences of FTO;iScience;2023-08